New
NeuroMedPro
The AI engine Fit Assessment
BetaUses AI/ML in healthcare to develop clinical neurodiagnostic tools for detecting brain lesions and seizures.
Blurb
Operator of a neuroscience and medicine programming company intended to detect lesions and seizures in the brain. The company offers to bring artificial intelligence-based clinical neurodiagnostic tools to market, enabling neurologists and neurosurgeons to get clinical decision-making support.
HQ Location
Little Rock (United States)
Founded
2021
Employees
1 - 10
Total funding raised
Not available
Funding Status
Not available
We combine our advanced skills in neuroscience, medicine, programming, and business to bring technology tools to life. Our current focus is using artificial intelligence, specifically machine learning, to accurately detect lesions and seizures in the brain.